Correlation Between China Pharma and Cronos

Can any of the company-specific risk be diversified away by investing in both China Pharma and Cronos at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Pharma and Cronos into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between China Pharma Holdings and Cronos Group, you can compare the effects of market volatilities on China Pharma and Cronos and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Pharma with a short position of Cronos. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Pharma and Cronos.

Diversification Opportunities for China Pharma and Cronos

0.51

Correlation Coefficient

China Pharma  Cronos

Very weak diversification

The 3 months correlation between China and Cronos is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding China Pharma Holdings and Cronos Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cronos Group and China Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Pharma Holdings are associated (or correlated) with Cronos. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cronos Group has no effect on the direction of China Pharma i.e., China Pharma and Cronos go up and down completely randomly.

Pair Corralation between China Pharma and Cronos

Given the investment horizon of 90 days China Pharma Holdings is expected to generate 2.49 times more return on investment than Cronos. However, China Pharma is 2.49 times more volatile than Cronos Group. It trades about 0.01 of its potential returns per unit of risk. Cronos Group is currently generating about -0.05 per unit of risk. If you would invest  26.00  in China Pharma Holdings on October 18, 2024 and sell it today you would lose (5.00) from holding China Pharma Holdings or give up 19.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

China Pharma Holdings  vs.  Cronos Group

China Pharma Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days China Pharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong technical indicators, China Pharma is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Cronos Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cronos Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with China Pharma and Cronos

The main advantage of trading using opposite China Pharma and Cronos positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Pharma position performs unexpectedly, Cronos can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cronos will offset losses from the drop in Cronos' long position.

The idea behind China Pharma Holdings and Cronos Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.